Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Scott

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell diseaseMark C Walters, Karen Hardy, Sandie Edwards, et al.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
Nature Communications|April 2, 2022
Defining the early stages of intestinal colonisation by whipwormsMaría A Duque-Correa, David Goulding, Faye H Rodgers, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 12, 2016
Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal ColonDavid Bernardo, Lydia Durant, Elizabeth R Mann, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Journal of Bacteriology|October 22, 2008
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patientsMatthew T G Holden, Helena M B Seth-Smith, Lisa C Crossman, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
American Journal of Hematology|November 11, 2014
Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registryHenry E Rice, Brian R Englum, Jennifer Rothman, et al.
Journal of Pediatric Surgery|November 29, 2015
Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemiaBrian R Englum, Jennifer Rothman, Sarah Leonard, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell diseaseMark C Walters, Karen Hardy, Sandie Edwards, et al.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
Nature Communications|April 2, 2022
Defining the early stages of intestinal colonisation by whipwormsMaría A Duque-Correa, David Goulding, Faye H Rodgers, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 12, 2016
Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal ColonDavid Bernardo, Lydia Durant, Elizabeth R Mann, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Journal of Bacteriology|October 22, 2008
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patientsMatthew T G Holden, Helena M B Seth-Smith, Lisa C Crossman, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
American Journal of Hematology|November 11, 2014
Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registryHenry E Rice, Brian R Englum, Jennifer Rothman, et al.
Journal of Pediatric Surgery|November 29, 2015
Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemiaBrian R Englum, Jennifer Rothman, Sarah Leonard, et al.
Pageof 26